StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)

Close on Nov 17, 2026Market cap $58.19MP/E –Yield –

PharmaCyte Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

PharmaCyte Biotech's revenue for the twelve months ending Apr 30, 2026 was $0. For fiscal 2026 it was $0. The highest annual figure on record is $126.00K in fiscal 2011.

Annual revenue

PeriodPeriod endValueChange
FY2026Apr 30, 2026$0–
FY2025Apr 30, 2025$0–
FY2024Apr 30, 2024$0–
FY2023Apr 30, 2023$0–
FY2022Apr 30, 2022$0–
FY2021Apr 30, 2021$0–
FY2020Apr 30, 2020$0–
FY2019Apr 30, 2019$0–
FY2018Apr 30, 2018$0–
FY2017Apr 30, 2017$0–
FY2016Apr 30, 2016$0–
FY2015Apr 30, 2015$0–
FY2014Apr 30, 2014$0-100.0%
FY2013Apr 30, 2013$12.16K-81.7%
FY2012Apr 30, 2012$66.56K-47.2%
FY2011Apr 30, 2011$126.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$0–
Q4 FY2026CQ1 2026Apr 30, 2026$0–
Q3 FY2026CQ4 2025Jan 31, 2026$0–
Q4 FY2025CQ1 2025Apr 30, 2025$0–
Q3 FY2025CQ4 2024Jan 31, 2025$0–
Q2 FY2025CQ3 2024Oct 31, 2024$0–
Q1 FY2025CQ2 2024Jul 31, 2024$0–
Q4 FY2024CQ1 2024Apr 30, 2024$0–
Q3 FY2024CQ4 2023Jan 31, 2024$0–
Q2 FY2024CQ3 2023Oct 31, 2023$0–
Q1 FY2024CQ2 2023Jul 31, 2023$0–
Q4 FY2023CQ1 2023Apr 30, 2023$0–
Q3 FY2023CQ4 2022Jan 31, 2023$0–
Q2 FY2023CQ3 2022Oct 31, 2022$0–
Q1 FY2023CQ2 2022Jul 31, 2022$0–
Q4 FY2022CQ1 2022Apr 30, 2022$0–
Q3 FY2022CQ4 2021Jan 31, 2022$0–
Q2 FY2022CQ3 2021Oct 31, 2021$0–
Q1 FY2022CQ2 2021Jul 31, 2021$0–
Q4 FY2021CQ1 2021Apr 30, 2021$0–
Q3 FY2021CQ4 2020Jan 31, 2021$0–
Q2 FY2021CQ3 2020Oct 31, 2020$0–
Q1 FY2021CQ2 2020Jul 31, 2020$0–
Q4 FY2020CQ1 2020Apr 30, 2020$0–
Q3 FY2020CQ4 2019Jan 31, 2020$0–
Q2 FY2020CQ3 2019Oct 31, 2019$0–
Q1 FY2020CQ2 2019Jul 31, 2019$0–
Q4 FY2019CQ1 2019Apr 30, 2019$0–
Q3 FY2019CQ4 2018Jan 31, 2019$0–
Q2 FY2019CQ3 2018Oct 31, 2018$0–
Q1 FY2019CQ2 2018Jul 31, 2018$0–
Q4 FY2018CQ1 2018Apr 30, 2018$0–
Q3 FY2018CQ4 2017Jan 31, 2018$0–
Q2 FY2018CQ3 2017Oct 31, 2017$0–
Q1 FY2018CQ2 2017Jul 31, 2017$0–
Q4 FY2017CQ1 2017Apr 30, 2017$0–
Q3 FY2017CQ4 2016Jan 31, 2017$0–
Q2 FY2017CQ3 2016Oct 31, 2016$0–
Q1 FY2017CQ2 2016Jul 31, 2016$0–

More PharmaCyte Biotech figures

See a number that looks wrong?